Sensitivity				Specificity
	TP/diseased		P value	change	TN/not diseased		P value	change
Type 2 vs Type 1	Type 2	Type 1			Type 2	Type 1
Van den Broek 2006	144/152	137/152	P = 0.19	+4.6% (‐1.3% to +10.5%)	674/744	740/744	P < 0.001	‐8.9% (‐11.0% to ‐6.7%)
Type 2 vs Type 4	Type 2	Type 4			Type 2	Type 4
Van den Broek 2006	144/152	127/152	P = 0.003	+11.1% (+4.3% to +18.1%)	674/744	731/744	P < 0.001	‐7.7% (‐10.0% to ‐5.4%)
Type 3 vs Type 1	Type 3	Type 1			Type 3	Type 1
Mens 2007b	60/60	113/127	P = 0.006	+11.0% (+5.6% to +16.5%)	115/124	678/711	P = 0.26	‐2.6%  (‐7.4% to +2.2%)
Dev 2004	17/17	21/21	P = 1.00	0% (not estimable)	13/13	9/9	P = 1.00	0% (not estimable)
Type 3 vs Type 4	Type 3	Type 4			Type 3	Type 4
Mens 2007b	60/60	58/60	P = 0.50	+3.3% (‐1.2% to +7.9%)	115/124	121/124	P = 0.14	‐4.8% (‐10.1% to +0.5%)
Dev 2004	17/17	69/85	P = 0.07	+18.8% (+10.5% to +27.1%)	13/13	54/54	P = 1.00	0% (not estimable)
Type 5 vs Type 1	Type 5	Type 1			Type 5	Type 1
Sharew 2009	167/168	167/168	P = 1.00	0% (‐1.6% to 1.6%)	490/500	484/500	P = 0.32	+1.2% (‐0.8% to +3.2%)